1-3 of 3
M. Gonzalez, MD
Close
Sort by
Journal Articles

Presence of DRB1*01 Allele in Multiple Myeloma Patients Is Associated with Indolent Disease.

M. Alcoceba, L. Marin, A. Balanzategui, M.E. Sarasquete, PhD, P. Martin-Jimenez, PhD, M.C. Chillon, PhD, M. Vargas, R. Corral, MD, E. Perez, MD, J. Fernandez-Calvo, MD, PhD, A. Martinez, MD, PhD, J.M. Hernandez, MD, PhD, Joan Blade, MD, PhD, J.J. Lahuerta, MD, PhD, R. Garcia-Sanz, MD, PhD, M. Gonzalez, MD, PhD, J.F. San Miguel, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1481.
https://doi.org/10.1182/blood.V110.11.1481.1481
Published: 2007
Journal Articles

Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL): A Comparison between French -Belgian-Swiss and Spanish Results.

L. Ades, MD, M. Sanz, MD, S. Chevret, MD, S. De Botton, MD, G. Martin, MD, E. Raffoux, MD, E. Vellenga, MD, A. Guerci, MD, M. Gonzalez, MD, A. Pigneux, MD, C. Rayon, MD, A.M. Stoppa, MD, J. De la Serna, MD, T. Pabst, MD, S. Meyer-Monard, MD, R. Parodi, MD, J. Bergua, MD, F. Rigal-Huguet, MD, A. Vekhoff, MD, S. Negri, MD, N. Fegueux, MD, A. Ferrant, MD, D. Bron, MD, H. Dombret, MD, L. Degos, MD, P. Fenaux, MD
Journal: Blood
Blood (2005) 106 (11): 544.
https://doi.org/10.1182/blood.V106.11.544.544
Published: 2005
Journal Articles

Searching Polymorphic Markers Associated with the Genetic Predisposition To Develop Therapy-Related Myelodysplastic Syndromes and Acute Myelogenous Leukemia T-(MDS/AML) after Myeloablative Chemotherapy.

Mar M. Tormo, MD, Vicent V. Guillem, PhD, Manuel M. Mata, PhD, Marcos M. Gonzalez, MD, Josep J. Nomdedeu, MD, Jordi J. Esteve, MD, Maria Jose M.J. Calasanz, MD, Maria Jose M.J. Terol, MD, Isabel I. Marugan, MD, Carlos C. Solano, MD
Journal: Blood
Blood (2005) 106 (11): 1446.
https://doi.org/10.1182/blood.V106.11.1446.1446
Published: 2005